Indo-Bangla Pharma signs deal with Afghan firm to export medicines | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
July 10, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JULY 10, 2025
Indo-Bangla Pharma signs deal with Afghan firm to export medicines

Stocks

TBS Report
09 July, 2025, 10:25 pm
Last modified: 10 July, 2025, 02:30 am

Related News

  • No price-sensitive news, yet shares of Rupali Bank, Indo-Bangla Pharma, City Insurance jump
  • Russia becomes first country to recognise Taliban government of Afghanistan
  • Chevron to resume Jalalabad gas project after Petrobangla clears $237m dues
  • Biman, My Freighter ink deal to boost cargo connectivity
  • Political stability in Bangladesh essential for progress on Teesta deal: Indian minister

Indo-Bangla Pharma signs deal with Afghan firm to export medicines

Before the DSE issued a query to the company, the share price of Indo-Bangla Pharmaceuticals had surged by 55%, rising from Tk9.1 on 22 June to Tk14.1 within 12 trading days

TBS Report
09 July, 2025, 10:25 pm
Last modified: 10 July, 2025, 02:30 am
Infographics: TBS
Infographics: TBS

Indo-Bangla Pharmaceuticals, a listed company on the stock exchanges, has signed a memorandum of understanding (MoU) with Salar Yousafzai Pharma, an Afghanistan-based firm, to export pharmaceutical products to the Afghan market.

A disclosure regarding the deal was published on the stock exchanges today (9 July) through the Dhaka Stock Exchange (DSE), a day after the company responded that there was no price-sensitive information (PSI) related to the recent surge in its share price.

Before the DSE issued a query to the company, the share price of Indo-Bangla Pharmaceuticals had surged by 55%, rising from Tk9.1 on 22 June to Tk14.1 within 12 trading days.

As per disclosure, Salar Yousafzai Pharma will act as the sole agent in Afghanistan. The tenure of the MoU is valid for 15 years from 2025 to 2040, and renewable upon mutual agreement.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The minimum order value will be $1.5 lakh per shipment, with regular exports plan, and payment terms 40% in advance TT, 60% pre-shipment. The exports will be made on a Free on Board (FOB) basis from Chattogram Port, meaning the buyer will bear the shipping costs and risks once the goods are loaded onto the vessel.

The company also said this strategic collaboration is expected to strengthen the Company's financial position through boosting export revenue, strengthening foreign currency earnings, and supporting long-term business growth, thereby enhancing shareholder value.

According to its financials reports, the company's revenue dropped by 53% to Tk7.69 crore in the first nine months of 2024-25 fiscal during the July to March quarter. 

It incurred a loss of Tk1.97 crore with per share loss of Tk0.17 for FY25. 

In FY24, it had incurred a loss of Tk4.09 crore with per share loss of Tk0.35, and paid 0.1% cash dividend for its shareholders. 

The pharmaceutical firm got listed on the stock exchange in 2018. As of June 2024, sponsor-directors held 24.43% shares, institutional investors 22.74% and the general shareholders held 52.83% shares of the company.

Indo-Bangla Pharmaceuticals Limited / Afganistan / deal

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Former prime minister Sheikh Hasina. File photo: Collected
    Crimes against humanity: ICT orders initiating trial in first July massacre case against Hasina
  • How S Alam’s Global Islami Bank cooked Tk2,259cr loss into Tk128cr profit
    How S Alam’s Global Islami Bank cooked Tk2,259cr loss into Tk128cr profit
  • Students sit for SSC exam at Motijheel Girls' High School on 10 April 2025. Photo: Mehedi Hasan/TBS
    SSC exam results out at 2pm today: Here's how you can check online and via SMS

MOST VIEWED

  • Graphics: TBS
    BB raises startup fund limit, drops upper age barrier
  • Workers pack undergarments at the packing section of a garment factory in Ashulia, on the outskirts of Dhaka, Bangladesh, April 19, 2025. Photo: REUTERS/Fatima Tuj Johora
    After US tariffs, jobs hang by a thread in Bangladesh's garments sector
  • Global Islami Bank rectifies 2023 figures, reports Tk2,259cr loss instead of Tk128cr profit
    Global Islami Bank rectifies 2023 figures, reports Tk2,259cr loss instead of Tk128cr profit
  • Bangladesh Bank Governor Ahsan H Mansur. TBS Sketch
    Audit reports of most banks contain cooked up data: BB governor
  • File photo of containers at Chattogram port/TBS
    US buyers push Bangladeshi exporters to share extra tariff costs
  • CA orders law enforcers to complete all election preparations by December
    CA orders law enforcers to complete all election preparations by December

Related News

  • No price-sensitive news, yet shares of Rupali Bank, Indo-Bangla Pharma, City Insurance jump
  • Russia becomes first country to recognise Taliban government of Afghanistan
  • Chevron to resume Jalalabad gas project after Petrobangla clears $237m dues
  • Biman, My Freighter ink deal to boost cargo connectivity
  • Political stability in Bangladesh essential for progress on Teesta deal: Indian minister

Features

Women are forced to fish in saline waters every day, risking their health to provide for their families. Photo: TBS

How Mongla’s women are bearing the brunt of rising salinity

17h | Panorama
Dr Mostafa Abid Khan. Sketch: TBS

Actual impact will depend on how US retailers respond: Mostafa Abid Khan

2d | Economy
Thousands gather to form Bangla Blockade in mass show of support. Photo: TBS

Rebranding rebellion: Why ‘Bangla Blockade’ struck a chord

2d | Panorama
The Mitsubishi Xpander is built with families in mind, ready to handle the daily carpool, grocery runs, weekend getaways, and everything in between. PHOTO: Akif Hamid

Now made-in-Bangladesh: 2025 Mitsubishi Xpander

3d | Wheels

More Videos from TBS

Trump threatens to impose 50 percent tariffs on Brazil

Trump threatens to impose 50 percent tariffs on Brazil

1h | TBS World
Can India stop water flow to Pakistan?

Can India stop water flow to Pakistan?

2h | TBS World
SSC exam results are out today, results will be available via SMS

SSC exam results are out today, results will be available via SMS

2h | TBS Today
Leaked audio: Jinping thought Trump was crazy

Leaked audio: Jinping thought Trump was crazy

13h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net